This bulletin was published on 28 August

PSCI welcomes Delpharm, Samsung Biologics, and Suven as first cohort of Supplier Partners

The Pharmaceutical Supply Chain Initiative (PSCI) has welcomed its first cohort of Supplier Partners under a new model to recognize suppliers within the pharmaceutical and healthcare industry that share its vision of building responsible supply chains.

Delpharm, Samsung Biologics, and Suven have joined the PSCI as Supplier Partners, receiving formal recognition of their commitment to the PSCI Principles, vision, and responsible business practices. These companies join a global community of pharmaceutical and healthcare companies working as one voice to drive responsible business practices.

This is a new category of partnership created as a response to the growing engagement and interest from pharmaceutical suppliers to be actively involved in PSCI activities. Supplier Partnership is open to companies in the industry that manufacture components or ingredients, manufacture finished pharmaceutical or medical products which are supplied to customers under the clients’ brand name or licence (CMOs), or a ‘white label’ service provider (such as CDOs or CROs).

Through this category, the PSCI seeks to strengthen its collaboration with suppliers, recognize those who engage, and bring their voice into relevant discussions alongside the wider membership. Supplier Partners will be able to benefit from access to the PSCI’s shared audit platform collaborate with the membership on areas of shared interest, and demonstrate their commitment to a shared vision of excellence in safety, environmental, and social outcomes across the industry.

Speaking of the new model, Dr. Deirdre O’Reilly, Chair of the PSCI & Senior Director of Global EHS Supplier Operations and Business Development at Viatris says,

I am delighted to welcome Delpharm, Samsung Biologics, and Suven as our first cohort of Supplier Partners. By solidifying the PSCI’s partnerships with suppliers, we create a stronger collaboration that promotes responsible sourcing practices across the industry. This unified approach empowers suppliers to have a voice and be recognized for their commitment to ethical sourcing and contribute to the positive impacts of the PSCI.

Nicolas Ragot, Managing Director at Delpharm says,

As a major CDMO to the pharmaceutical industry, Delpharm is proud to join the PSCI community as an official Supplier Partner. Delpharm believes that every company has a key role to play in making a difference and driving responsible value chain practices. Becoming a Supplier Partner demonstrates Delpharm’s commitment to drive excellence in safety, environmental, and social outcomes within our company and across the global pharmaceutical and healthcare supply chain.

John Rim, CEO and President of Samsung Biologics says,

The PSCI’s Supplier Partnership is a strong reaffirmation of Samsung Biologics’ commitment to achieve net zero across the supply chain. We hope to work collectively with global healthcare and pharmaceutical companies as well as suppliers to build more sustainable and responsible supply chains. We will integrate the PSCI Principles into our business practices and promote responsible conduct among our suppliers to drive sustainable change across the supply chain, contributing to creating a healthier future.

Metlapalli Srinivasu, Vice President Corp. Head of EHS & ESG at Suven Pharmaceuticals says,

Being a Supplier Partner represents a significant milestone for Suven Pharma. It accentuates our commitment to delivering high-quality pharmaceutical solutions and reinforces our role as a trusted partner in advancing global health. We are excited to contribute our expertise and collaborate closely with the PSCI to achieve our shared goals.

About the PSCI

The PSCI is the leading membership association for pharmaceutical and healthcare companies. Through our three modes of impact, Audit, Capability Building, and Projects, we work as one voice across the industry to build responsible value chains. Our 80+ members work collectively to achieve our vision for excellence in safety, environmental, and social outcomes across the global pharma and healthcare value chain.

For more information about Supplier Partnership, click here.